Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 2Head & Neck 2Breast 2Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Pancreatic Neoplasms 14Colorectal Neoplasms 13Rectal Neoplasms 5Colonic Neoplasms 4Adenocarcinoma 4Liver Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Neoplasm Metastasis 2Melanoma 2Esophageal Neoplasms 2Barrett Esophagus 2Adenocarcinoma Of Esophagus 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Resectable Pancreatic Ductal Adenocarcinoma 1Prostatic Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Obesity 1Non-DM Stage II High-risk Colorectal Cancer 1Neoplasms 1Motor Activity 1Lymphatic Metastasis 1Lung Neoplasms 1Kidney Neoplasms 1Insulin Resistance 1Hepatitis C, Chronic 1Glioma 1

Interventions

exendin (9-39) 1Water 1Telemedicine 1Sulfasalazine 1Saline Solution 1Preoperative Exercise 1Octreotide 1Metformin 1Gastric Bypass 1Exercise 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Insulin Resistance × Metformin × Gastrointestinal × Clear all
NCT01340300 2018-06-06

Exercise and Metformin in Colorectal and Breast Cancer Survivors

Dana-Farber Cancer Institute

Phase 2 Completed
139 enrolled 18 charts
BreastGastrointestinal

Breast Neoplasms, Insulin Resistance, Motor Activity, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡